Track the Thyrocare Tech share price and the full management transaction log of the company, a publicly traded company based in India. Shares trade on the IN market, under the oversight of SEBI (PIT + SAST). Operating in the Technology sector, Thyrocare Tech has logged 11 public disclosures. Market capitalisation: €92.6bn. The latest transaction was reported on 25 August 2026 (Pledge). Among the most active insiders: Docon Technologies Private Limited. Every trade is openly available.
11
Insider Decl.
n/a
Thresholds
n/a
1 ops.
Buy Volume
€89m
6 ops.
Sell Volume
Analyst consensus: bullish or bearish?
Analysts rate Thyrocare Tech Strong Buy (bullish), based on 5 analysts. Average price target: ₹663.00.
36Σ signal
Buys n/a€89m Sells
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Fundamental score
Ranked 8,884 of 28,857 companies
61.2
score / 100
Value
34
Quality
88
FCF yld2.1%
Earn yld1.8%
EV/EBITDA34.0x
ROE29%
Gross mgn73%
Net mgn20%
Debt/EBITDA0.2x
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Σ
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
200 shares@ ₹471.600.0001% mcap100.0% of flowEquity SharesMarket SaleSEBI:e91e5a707bf02cd67d9702f252ff555af3177636
11 of 11 declarations
About Thyrocare Tech
Thyrocare Tech is a company specializing in medical diagnostic services and laboratory testing. It primarily operates in the Indian market and offers a wide range of health tests.